349 related articles for article (PubMed ID: 35530147)
41. An ultra-sensitive and easy-to-use assay for sensing human UGT1A1 activities in biological systems.
Zhu YD; Pang HL; Zhou QH; Qin ZF; Jin Q; Finel M; Wang YN; Qin WW; Lu Y; Wang DD; Ge GB
J Pharm Anal; 2020 Jun; 10(3):263-270. PubMed ID: 32612873
[TBL] [Abstract][Full Text] [Related]
42. Role of microRNAs in the regulation of drug metabolism and disposition.
Yu AM
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1513-28. PubMed ID: 19785514
[TBL] [Abstract][Full Text] [Related]
43. Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants.
Nebert DW
Clin Chem Lab Med; 2000 Sep; 38(9):857-61. PubMed ID: 11097340
[TBL] [Abstract][Full Text] [Related]
44. Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals.
den Braver-Sewradj SP; den Braver MW; van Dijk M; Zhang Y; Dekker SJ; Wijaya L; Vermeulen NPE; Richert L; Commandeur JNM; Vos JC
Curr Drug Metab; 2018; 19(4):370-381. PubMed ID: 29318967
[TBL] [Abstract][Full Text] [Related]
45. Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.
Tolson AH; Wang H
Adv Drug Deliv Rev; 2010 Oct; 62(13):1238-49. PubMed ID: 20727377
[TBL] [Abstract][Full Text] [Related]
46. The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family.
Esteves F; Rueff J; Kranendonk M
J Xenobiot; 2021 Jun; 11(3):94-114. PubMed ID: 34206277
[TBL] [Abstract][Full Text] [Related]
47. Spectrophotometric Assays for Sensing Tyrosinase Activity and Their Applications.
Fan YF; Zhu SX; Hou FB; Zhao DF; Pan QS; Xiang YW; Qian XK; Ge GB; Wang P
Biosensors (Basel); 2021 Aug; 11(8):. PubMed ID: 34436092
[TBL] [Abstract][Full Text] [Related]
48. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
Ozawa S
Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
[TBL] [Abstract][Full Text] [Related]
49. High-Throughput and Reliable Isotope Label-free Approach for Profiling 24 Metabolic Enzymes in FVB Mice and Sex Differences.
Chen J; Zhu L; Li X; Zheng H; Yan T; Xie C; Zeng S; Yu J; Jiang H; Lu L; Qi X; Wang Y; Hu M; Liu Z
Drug Metab Dispos; 2017 Jun; 45(6):624-634. PubMed ID: 28356314
[TBL] [Abstract][Full Text] [Related]
50. Gold Nanoparticles Perturb Drug-Metabolizing Enzymes and Antioxidants in the Livers of Male Rats: Potential Impact on Drug Interactions.
Al-Hamadani MYI; Alzahrani AM; Yousef MI; Kamel MA; El-Sayed WM
Int J Nanomedicine; 2020; 15():5005-5016. PubMed ID: 32764932
[TBL] [Abstract][Full Text] [Related]
51. Prediction of metabolism-induced hepatotoxicity on three-dimensional hepatic cell culture and enzyme microarrays.
Yu KN; Nadanaciva S; Rana P; Lee DW; Ku B; Roth AD; Dordick JS; Will Y; Lee MY
Arch Toxicol; 2018 Mar; 92(3):1295-1310. PubMed ID: 29167929
[TBL] [Abstract][Full Text] [Related]
52. The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
Tomalik-Scharte D; Lazar A; Fuhr U; Kirchheiner J
Pharmacogenomics J; 2008 Feb; 8(1):4-15. PubMed ID: 17549068
[TBL] [Abstract][Full Text] [Related]
53. Interactions of drug-metabolizing enzymes with the Chinese herb Psoraleae Fructus.
Zhou QH; Zhu YD; Zhang F; Song YQ; Jia SN; Zhu L; Fang SQ; Ge GB
Chin J Nat Med; 2019 Nov; 17(11):858-870. PubMed ID: 31831132
[TBL] [Abstract][Full Text] [Related]
54. Mechanism-based inhibitory and peroxisome proliferator-activated receptor α-dependent modulating effects of silybin on principal hepatic drug-metabolizing enzymes.
Wang H; Yan T; Xie Y; Zhao M; Che Y; Zhang J; Liu H; Cao L; Cheng X; Xie Y; Li F; Qi Q; Wang G; Hao H
Drug Metab Dispos; 2015 Apr; 43(4):444-54. PubMed ID: 25587127
[TBL] [Abstract][Full Text] [Related]
55. Expression of drug metabolizing enzymes and transporters in the cochlea: Implications for drug delivery and ototoxicity.
Kennon-McGill S; Clemens MM; McGill MR
Hear Res; 2019 Aug; 379():98-102. PubMed ID: 31121337
[TBL] [Abstract][Full Text] [Related]
56. In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery.
Masimirembwa CM; Thompson R; Andersson TB
Comb Chem High Throughput Screen; 2001 May; 4(3):245-63. PubMed ID: 11375740
[TBL] [Abstract][Full Text] [Related]
57. Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM; Alzahrani AJ; Mahmoud A
Saudi J Biol Sci; 2021 Jan; 28(1):628-634. PubMed ID: 33424349
[TBL] [Abstract][Full Text] [Related]
58. Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.
Stingl JC; Brockmöller J; Viviani R
Mol Psychiatry; 2013 Mar; 18(3):273-87. PubMed ID: 22565785
[TBL] [Abstract][Full Text] [Related]
59. Chemical Probes for Human UDP-Glucuronosyltransferases: A Comprehensive Review.
Lv X; Zhang JB; Hou J; Dou TY; Ge GB; Hu WZ; Yang L
Biotechnol J; 2019 Jan; 14(1):e1800002. PubMed ID: 30192065
[TBL] [Abstract][Full Text] [Related]
60. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
Niwa T; Murayama N; Yamazaki H
Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
